Most recent by Jason L. Dragoo, MD, FAAOS
VIDEO: Dragoo speaks about future of orthobiologics
WASHINGTON — Jason L. Dragoo, MD, FAAOS, spoke about the next generation of orthobiologics at the American Association of Orthopaedic Surgeons Next Generation of Biologics Symposium, here.
VIDEO: Biorepository allows surgeons to thoroughly examine PRP
NEW ORLEANS — In this video, Jason L. Dragoo, MD, discusses how implementation of the National Biorepository Network of the Biologic Association has allowed surgeons to examine platelet-rich plasma more thoroughly.
VIDEO: Use FDA-approved technologies to stay out of trouble with FDA
WAIKOLOA, Hawaii — In this video from Orthopedics Today Hawaii 2022, Jason L. Dragoo, MD, spoke about modern-day biologics, what orthopedic surgeons should be telling patients and how stay out of trouble with the FDA.
At Issue: Stem cell therapy
Articular cartilage stands to benefit the most from stem cell therapy. While stem cells have been identified in nearly every human tissue, articular cartilage contains few regenerative cells. Cartilage is avascular and is devoid of a perivascular (pericyte) stem cell population, so when injury occurs, there is little response from the cartilage tissue itself. Migrating synovial cells may contribute to the body’s often-inadequate healing response.